Navigation Links
Researchers examine role of inflammatory mechanisms in a healing heart
Date:11/30/2011

Virginia Commonwealth University researchers have found that an inflammatory mechanism known as inflammasome may lead to more damage in the heart following injury such as a heart attack, pointing researchers toward developing more targeted strategies to block the inflammatory mechanisms involved.

Following a heart attack, an inflammatory process occurs in the heart due to the lack of oxygen and nutrients. This process helps the heart to heal, but may also promote further damage to the heart. The mechanisms by which the heart responds to injury are not fully understood, so researchers have been examining the cellular pathways involved to gain further insight.

In a study published online the week of Nov. 21 in the Proceedings of the National Academy of Sciences, researchers addressed the role of a specific inflammatory mechanism, called inflammasome, during the process of healing in the heart. Using an animal model, the team found that inflammasome amplifies the response by generating the production of a key inflammatory mediator known as Interleukin-1β. Further, they described that pharmacologic inhibition of the formation of inflammasome prevents heart enlargement and dysfunction.

"Defining the role of the inflammasome in the response to injury in the heart and the possibility to intervene opens a new area of investigation for the prevention and treatment of heart failure following a heart attack," said Antonio Abbate, M.D., assistant professor of medicine in the VCU Department of Internal Medicine and Division of Cardiology.

According to Abbate, who serves as the interim director for the cardiac intensive care unit at the VCU Pauley Heart Center, this study supports the team's previous findings that showed that Interleukin-1β affects the heart, and blocking Interleukin-1β benefits patients of heart attack and heart failure.

"Based on the findings of the current study we are even more convinced that blocking Interleukin-1β may be safe and beneficial, and we are now exploring novel ways to do so," he said.

Abbate said there are four ongoing clinical trials at the VCU Pauley Heart Center in patients with various heart conditions treated with a drug called anakinra which blocks Interleukin-1β.

Abbate and his team continue to examine the molecular mechanisms of inflammasome formation and heart injury, and hope to determine new ways to intervene with potentially more targeted strategies in the future.


'/>"/>
Contact: Sathya Achia Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
Source:Eurekalert

Related medicine news :

1. WSU researchers use a 3D printer to make bone-like material
2. Presumed consent not answer to solving organ shortage in US, researchers say
3. Researchers validate preclinical effectiveness of TB drug target
4. Researchers surprised to find fatty liver disease poses no excess risk for death
5. Moffitt Cancer Center researchers find men less willing to be screened for cancer
6. MU researchers find synthetic RNA lessens severity of fatal disease
7. Researchers search for culprit behind dry eyes, mouths and more
8. MU researchers develop tool that saves time, eliminates mistakes in diabetes care
9. Researchers discover new way to form extracellular vesicles
10. Researchers discover Achilles heel in lethal form of prostate cancer
11. Jackson Laboratory researchers uncover steps in synapse building, pruning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... Calif. (PRWEB) , ... March 01, 2017 , ... Award-winning ... has completed 25 medical mission trips in underdeveloped nations, averaging more than one trip ... 2016. An article on the website features the details of his charitable ...
(Date:3/1/2017)... ... March 01, 2017 , ... NYC based Integrated practice Living Well ... to announce the addition of Orthopaedic Surgeon Dr. Donald E. Heitman. Dr. ... Cornell University with a Bachelor of Science degree in biology. He then obtained his ...
(Date:3/1/2017)... ... 01, 2017 , ... “There is Comfort for the Soul”: a loving account ... their all-too-brief time together, and the soul-healing comfort provided by God’s presence in the ... published author, Jerie A. Tau, a dog-loving medical professional whose work takes her to ...
(Date:3/1/2017)... ... ... Way: Key To One Flesh”: a collection of real marital scenarios and solutions for ... Cecilia Chiam, a writer who emigrated to the United States in 1978. , ... problems with the guidance and support of Holy Scripture. , “This is a ...
(Date:3/1/2017)... ... March 01, 2017 , ... Adherence Compliance, the ... Cannabis Compliance Program for Regulatory Agencies. The regulatory agency program is the first ... internal or outsourced compliance program options, as well as an app for inspections ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Mar 01, 2017 ... Research and Markets has announced ... to 2017" report to their offering. The ... report provides understanding and access to partnering deals and agreements entered ... provides an analysis of partnering deals. The majority of deals are ...
(Date:3/1/2017)... Research and Markets has announced the addition of the ... to their offering. ... This analysis is one of the most accurate studies performed ... financial data derived from varied research sources to present unique and ... market during the next five years, including a deep dive analysis ...
(Date:3/1/2017)... , March 1, 2017  Numotion, the nation,s leading ... availability of Tek RMD ("robotic mobilization device") by Matia ... Tek RMD is a motorized standing movement device that ... manual wheelchair to complete everyday activities from a standing ... a Tek RMD unassisted. Numotion is the exclusive distributor ...
Breaking Medicine Technology: